HRGN
Harvard Apparatus Regenerative Technology, Inc.
Key Financials
Net Income
$-6869000
↑ 11.2%
Revenue
$704000
↑ 63.7%
Gross Profit
$0
NaN%
Operating Income
$-6915000
↑ 10.5%
Total Liabilities
$1.6M
↑ 32.8%
EPS (Diluted)
$-0.67
↓ 21.8%
Total Assets
$2.7M
↓ 39.7%
Cash & Equivalents
$1.4M
↓ 45.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 4/28/2026 | View on SEC |
| DEF 14A | 4/23/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 10-K | 3/19/2026 | View on SEC |
| D | 1/6/2026 | View on SEC |
| 8-K | 1/6/2026 | View on SEC |
| 4 | 12/1/2025 | View on SEC |
| 10-Q | 11/7/2025 | View on SEC |
| 4 | 10/1/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HRGN |
| Company Name | Harvard Apparatus Regenerative Technology, Inc. |
| CIK | 1563665 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (774) 233-7300 |